P. Wislocki

发表

Environmental effects of the anti-sea lice (Copepoda: Caligidae) therapeutant emamectin benzoate under commercial use conditions in the marine environment

D. Baird, T. Telfer, J. Mchenery, 2006 .

Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity.

D. Jerina, W. Levin, H. Yagi, 1978, Science.

Drug residue formation from ronidazole, a 5-nitroimidazole. VIII. Identification of the 2-methylene position as a site of protein alkylation.

A. Y. Lu, G. Miwa, P. Wislocki, 1992, Chemico-biological interactions.

Environmental effects of the usage of avermectins in livestock.

P. Wislocki, W. Vandenheuvel, B. Halley, 1993, Veterinary parasitology.

Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay.

A. Y. Lu, F. Beland, P. Fu, 1986, Carcinogenesis.

Photodegradation of avermectin B1a thin films on glass

W. Feely, B. Arison, L. Colwell, 1991 .

Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.

D. Jerina, A. Conney, W. Levin, 1978, Cancer research.

The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.

J. Miller, E. Miller, P. Borchert, 1976, Cancer research.

The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole.

J. Miller, E. Miller, P. Borchert, 1973, Cancer research.

Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin.

D. Jerina, A. Conney, W. Levin, 1977, Cancer research.

A uniform procedure to estimate the predicted environmental concentration of the residues of veterinary medicines in soil

P. Wislocki, L. van Leemput, Katrin R. I. Spaepen, 1997 .

Tumor-initiating ability of the twelve monomethylbenz[a]anthracenes.

A. Y. Lu, P. Fu, P. Wislocki, 1982, Carcinogenesis.

Carcinogenicity of 2-hydroxybenzo(a)pyrene and 6-hydroxybenzo(a)pyrene in newborn mice.

D. Jerina, A. Conney, W. Levin, 1979, Cancer research.

Marked differences in the carcinogenic activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene in newborn mice.

D. Jerina, A. Conney, D. Thakker, 1978, Cancer research.

In vitro Reactions of the Diastereomeric 9,10-Epoxides of (+) and (—)-trans-7,8-Dihydroxy-7,8-dihydrobenzo-[a]pyrene with Polyguanylic Acid and Evidence for Formation of an Enantiomer of Each Diastereomeric 9,10-Epoxide from Benzo[a]pyrene in Mouse Skin

D. Jerina, A. Conney, W. Levin, 1977 .

Acute toxicity of emamectin benzoate (SLICETM) in fish feed to American lobster, Homarus americanus.

K. Haya, L. Burridge, R. Greenhalgh, 2004 .

Tumorigenicity Studies with Diol-Epoxides of Benzo(a)pyrene Which Indicate That (Â±)-trans-70,8a-Dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene Is an Ultimate Carcinogen in Newborn Mice

Haruhiko, Yagi, M. Jerina, 2006 .

Mutagenicityand Cytotoxicityof Benzo(a)pyreneBenzo-Ring Epoxides

D. Jerina, A. Conney, W. Levin, 1976 .

Environmental Aspects of Abamectin Use in Crop Protection

P. Wislocki, R. A. Dybas, L. S. Grosso, 1989 .

Aged Soil Column Leaching of Emamectin Benzoate (MAB1a)

R. Robinson, P. Wislocki, J. L. Reynolds, 1998 .

Chapter 7 – Reactions Catalyzed by the Cytochrome P-450 System

A. Y. Lu, G. Miwa, P. Wislocki, 1980 .

Tumorigenicity of the diastereomeric benz[a]anthracene 3,4-diol-1,2-epoxides and the (+)- and (-)-enantiomers of benz[a]anthracene 3,4-dihydrodiol in newborn mice.

D. Jerina, A. Conney, D. Thakker, 1979, Journal of the National Cancer Institute.

Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites.

J. Miller, H. Rosenkranz, E. Miller, 1977, Cancer research.

High mutagenicity and toxicity of a diol epoxide derived from benzo(a)pyrene.

D. Jerina, A. Conney, W. Levin, 1976, Biochemical and biophysical research communications.

Exceptional carcinogenic activity of benz[a]anthracene 3,4-dihydrodiol in the newborn mouse and the bay region theory.

M. Schaefer-Ridder, D. Jerina, J. Karle, 1978, Cancer research.

Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.

D. Jerina, A. Conney, W. Levin, 1976, Cancer research.

9 – Mutagenicity and Carcinogenicity of Benzo[a]pyrene and Benzo[a]pyrene Derivatives

D. Jerina, A. Conney, W. Levin, 1978 .

High carcinogenicity of 2-hydroxybenzo(a)pyrene on mouse skin.

D. Jerina, A. Conney, W. Levin, 1977, Cancer research.

Drug residue formation from ronidazole, a 5-nitroimidazole. VI. Lack of mutagenic activity of reduced metabolites and derivatives of ronidazole.

A. Y. Lu, M. O. Bradley, F. J. Wolf, 1984, Chemico-biological interactions.

Mechanism of Metabolic Activation of Nitroimidazoles

A. Y. Lu, P. Wislocki, 1991 .

Drug residue formation from ronidazole, a 5-nitro-imidazole. IV. The role of the microflora.

A. Y. Lu, P. Goldman, G. Miwa, 1983, Chemico-biological interactions.

Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation.

A. Y. Lu, S. West, F. J. Wolf, 1982, Chemico-biological interactions.

Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.

D. Jerina, A. Conney, D. Thakker, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.

A. Y. Lu, D. Jerina, A. Conney, 1976, Cancer research.

Metabolism and Biological Activity of Benzo[a]pyrene and Its Metabolic Products

D. Jerina, A. Conney, G. Holder, 1977 .

Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles.

C. Wang, J. Walsh, G. Miwa, 1987, Journal of medicinal chemistry.

Metabolism of thiabendazole in laying hen and lactating goats

A. Chukwudebe, P. Wislocki, W. Vandenheuvel, 1994 .

Tissue distribution, metabolism, and residue depletion study in Atlantic salmon following oral administration of [3H]emamectin benzoate.

R. Robinson, P. Wislocki, H. Kim-Kang, 2004, Journal of agricultural and food chemistry.

Bioaccumulation potential of 4'-epi-(Methylamino)-4"-deoxyavermectin B1a benzoate (Emamectin benzoate) in bluegill sunfish

A. Chukwudebe, P. Wislocki, J. Swigert, 1996 .

Toxicity of emamectin benzoate to mallard duck and northern bobwhite quail

A. Chukwudebe, P. Wislocki, J. Beavers, 1998 .

Immobility of Emamectin Benzoate in Soils

W. Feely, P. Wislocki, M. Mushtaq, 1996 .

Mutagenicity of benzylic acetates, sulfates and bromides of polycyclic aromatic hydrocarbons.

R. K. Saugier, E. Cavalieri, E. Rogan, 1986, Chemico-biological interactions.

Toxicity of emamectin benzoate foliar dislodgeable residues to two beneficial insects

D. L. Cox, S. Palmer, A. Chukwudebe, 1997 .

Activating enzymes: multiple monooxygenase forms with different substrate preferences as related to toxic effects.

A. Y. Lu, G. Miwa, S. West, 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Development of a unified approach to evaluate the toxicological potential of bound residues.

A. Y. Lu, S. H. Chiu, P. Wislocki, 1990, Drug metabolism reviews.

TISSUE DRUG RESIDUES AND THEIR

A. Y. Lu, G. Miwa, S. H. Chiu, 1987 .

Tissue drug residues and their toxicological significance.

A. Y. Lu, G. Miwa, S. H. Chiu, 1987, Drug metabolism reviews.

Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.

R. Gingell, P. Wislocki, 1980, Mutation research.

Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.

A. Y. Lu, P. Wislocki, M. Chou, 1980, Cancer research.

Bioconcentration and metabolism of thiabendazole [2-(4-thiazolyl)-1h-benzimidazole] in bluegill sunfish, Lepomis macrochirus

K. Robillard, M. Hirsch, P. Wislocki, 1997 .

Tumorigenicity of 7,12-dimethylbenz[a]anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse.

A. Y. Lu, M. Juliana, J. Macdonald, 1981, Carcinogenesis.

Epoxidation reactions catalyzed by rat liver cytochromes P-450 and P-448 occur at different faces of the 8,9-double bond of 8-methylbenz[a]anthracene.

P. Fu, P. Wislocki, M. Chou, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Residues of avermectin B1a in rotational crops and soils following soil treatment with [14C]avermectin B1a

H. A. Moye, M. H. Malagodi, J. Yoh, 1987 .

Bioconcentration and depuration of avermectin B1a in the bluegill sunfish

T. A. Jacob, W. V. Heuvel, P. Wislocki, 1996 .

Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)- 1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test.

H. Mrozik, F. J. Wolf, P. Wislocki, 1984, Mutation research.

Metabolism and Biological Activity

D. Jerina, A. Conney, G. Holder, 1977 .

Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteine.

A. Y. Lu, F. J. Wolf, P. Wislocki, 1984, Chemico-biological interactions.

Formation and biological evaluation of ronidazole bound residues.

A. Y. Lu, P. Wislocki, 1990, Drug metabolism reviews.

Studies on the mechanism of activation and the mutagenicity of ronidazole, a 5-nitroimidazole.

A. Y. Lu, J. Walsh, G. Miwa, 1986, Advances in experimental medicine and biology.

Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro.

A. Y. Lu, F. J. Wolf, P. Wislocki, 1982, Chemico-biological interactions.

Uptake of emamectin benzoate residues from soil by rotational crops

W. Feely, T. Burnett, A. Chukwudebe, 1996 .

Residue depletion study and withdrawal period for flunixin-N-methyl glucamine in bovine milk following intravenous administration.

T. Terhune, K. Thompson, P. Wislocki, 2003, Journal of agricultural and food chemistry.